Koninklijke Philips (PHG) Non-Current Deffered Revenue (2017 - 2026)

Koninklijke Philips (PHG) recorded quarterly Non-Current Deffered Revenue of $512.8 million in Q1 2026, down 3.82% quarter-over-quarter from $533.1 million in Q4 2025, and up 18.32% on a YoY basis from $433.4 million in Q1 2025.

Koninklijke Philips (PHG) Non-Current Deffered Revenue (2017 - 2026) Analysis & Trends

Koninklijke Philips' Non-Current Deffered Revenue history runs 10 years deep, the most recent figure standing at $512.8 million for Q1 2026.

  • In Q1 2026, Non-Current Deffered Revenue rose 18.32% year-over-year to $512.8 million; the TTM figure through Mar 2026 stood at $512.8 million (up 18.32% YoY), while the FY2025 annual figure was $533.1 million, up 15.76% from the prior year.
  • Non-Current Deffered Revenue was $512.8 million for Q1 2026 at Koninklijke Philips, down from $533.1 million in the prior quarter.
  • In the past five years, Non-Current Deffered Revenue ranged from a high of $537.9 million in Q2 2023 to a low of $433.4 million in Q1 2025.
  • Historically, Non-Current Deffered Revenue has averaged $496.6 million across 5 years, with a median of $504.6 million in 2023.
  • The sharpest annual moves came in 2024 and 2026: Non-Current Deffered Revenue slipped 10.71% in 2024, then gained 18.32% in 2026.
  • A 5-year view of Non-Current Deffered Revenue shows it stood at $525.4 million in 2022, then declined by 3.96% to $504.6 million in 2023, then fell by 8.73% to $460.6 million in 2024, then increased by 15.76% to $533.1 million in 2025, then fell by 3.82% to $512.8 million in 2026.
  • The last three Non-Current Deffered Revenue figures came in at $512.8 million (Q1 2026), $533.1 million (Q4 2025), and $485.2 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Deffered Revenue (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn -
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn -
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn -
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn -
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 512.79 Mn
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn -
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -
10 Zimmer Biomet Holdings 17.18 Bn 16.77 Bn 1.51 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 512.79 Mn
Dec 31, 2025 533.13 Mn
Sep 30, 2025 485.16 Mn
Jun 30, 2025 466.37 Mn
Mar 31, 2025 433.38 Mn
Dec 31, 2024 460.56 Mn
Jun 30, 2024 480.29 Mn
Dec 31, 2023 504.62 Mn
Jun 30, 2023 537.93 Mn
Dec 31, 2022 525.43 Mn
Jun 30, 2022 522.86 Mn
Dec 31, 2021 510.21 Mn
Jun 30, 2021 507.00 Mn
Dec 31, 2020 480.49 Mn
Jun 30, 2020 395.42 Mn
Dec 31, 2019 385.20 Mn
Jun 30, 2019 326.98 Mn
Dec 31, 2018 257.96 Mn
Jun 30, 2018 263.75 Mn
Dec 31, 2017 293.18 Mn